CH679210A5 - - Google Patents
Download PDFInfo
- Publication number
- CH679210A5 CH679210A5 CH3835/89A CH383589A CH679210A5 CH 679210 A5 CH679210 A5 CH 679210A5 CH 3835/89 A CH3835/89 A CH 3835/89A CH 383589 A CH383589 A CH 383589A CH 679210 A5 CH679210 A5 CH 679210A5
- Authority
- CH
- Switzerland
- Prior art keywords
- percent
- component
- composition
- eye
- amount
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26286688A | 1988-10-26 | 1988-10-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH679210A5 true CH679210A5 (el) | 1992-01-15 |
Family
ID=22999400
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH3835/89A CH679210A5 (el) | 1988-10-26 | 1989-10-24 |
Country Status (24)
| Country | Link |
|---|---|
| JP (1) | JPH02164830A (el) |
| KR (1) | KR900005973A (el) |
| AU (1) | AU626928B2 (el) |
| BE (1) | BE1003578A4 (el) |
| CA (1) | CA2001502A1 (el) |
| CH (1) | CH679210A5 (el) |
| DE (1) | DE3935517A1 (el) |
| DK (1) | DK531289A (el) |
| ES (1) | ES2020032A6 (el) |
| FI (1) | FI895064A0 (el) |
| FR (1) | FR2638089A1 (el) |
| GB (1) | GB2224205B (el) |
| GR (1) | GR1000611B (el) |
| HU (1) | HU203046B (el) |
| IL (1) | IL92120A (el) |
| IT (1) | IT1237824B (el) |
| LU (1) | LU87613A1 (el) |
| MY (1) | MY106271A (el) |
| NL (1) | NL8902657A (el) |
| NO (1) | NO894266L (el) |
| NZ (1) | NZ231131A (el) |
| PT (1) | PT92120B (el) |
| SE (1) | SE8903583L (el) |
| ZA (1) | ZA898140B (el) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2222770B (en) * | 1988-09-16 | 1992-07-29 | Sandoz Ltd | Pharmaceutical compositions containing cyclosporins |
| CA2002147A1 (en) * | 1988-11-07 | 1990-05-07 | Shuichi Morikawa | Production process for polyimide fibers |
| US5540931A (en) * | 1989-03-03 | 1996-07-30 | Charles W. Hewitt | Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants |
| US4996193A (en) * | 1989-03-03 | 1991-02-26 | The Regents Of The University Of California | Combined topical and systemic method of administration of cyclosporine |
| FR2670629B1 (fr) * | 1990-12-17 | 1995-03-10 | Moving Magnet Tech | Actionneur electromagnetique monophase rotatif. |
| US6262022B1 (en) | 1992-06-25 | 2001-07-17 | Novartis Ag | Pharmaceutical compositions containing cyclosporin as the active agent |
| ZA927277B (en) * | 1991-10-02 | 1993-05-19 | Boston Ocular Res | Dry eye treatment process and solution. |
| JP3631490B2 (ja) | 1992-05-13 | 2005-03-23 | ノバルティス ファーマ株式会社 | シクロスポリン含有眼科用組成物 |
| US5830508A (en) * | 1992-08-06 | 1998-11-03 | Deo Corporation | Composition for treating dry eye |
| US5366739A (en) * | 1992-08-06 | 1994-11-22 | Deo Corporation | Method of ophthalmic drug delivery |
| DK0589843T3 (da) | 1992-09-25 | 2002-04-02 | Novartis Ag | Cyclosporinholdige farmaceutiske præparater |
| US5698533A (en) * | 1994-07-26 | 1997-12-16 | Kang; Meng-Che | Ophthalmic pharmaceutical composition |
| HUT77283A (hu) | 1994-11-03 | 1998-03-30 | Novartis Ag. | Egyszerű összetételű, a hatóanyagot biológiailag jól hozzáférhetően tartalmazó, orális alkalmazásra szánt új ciklosporinkészítmény és eljárás az előállítására |
| US5827822A (en) * | 1996-03-25 | 1998-10-27 | Sangstat Medical Corporation | Cyclosporin a formulations as nanoparticles |
| US5834017A (en) * | 1995-08-25 | 1998-11-10 | Sangstat Medical Corporation | Oral cyclopsporin formulations |
| US5766629A (en) * | 1995-08-25 | 1998-06-16 | Sangstat Medical Corporation | Oral cyclosporin formulations |
| US5962019A (en) * | 1995-08-25 | 1999-10-05 | Sangstat Medical Corporation | Oral cyclosporin formulations |
| ES2229473T3 (es) | 1997-01-30 | 2005-04-16 | Novartis Ag | Composiciones farmaceuticas sin aceite que contienen ciclosporina a. |
| US6254860B1 (en) * | 1999-04-13 | 2001-07-03 | Allergan Sales, Inc. | Ocular treatment using cyclosporin-A derivatives |
| US7557082B2 (en) | 2006-03-03 | 2009-07-07 | Allergan, Inc. | Treatment with cyclosporin A |
| JP2011502990A (ja) * | 2007-11-05 | 2011-01-27 | ボーシュ アンド ローム インコーポレイティド | 薬物送達用ビヒクルとしての水非混和性物質 |
| AU2010256652B2 (en) * | 2009-06-05 | 2015-11-26 | Allergan, Inc. | Artificial tears and therapeutic uses |
| US10279005B2 (en) | 2014-11-25 | 2019-05-07 | Allergan, Inc. | Stabilized omega-3 ophthalmic compositions |
| EP4201398A1 (en) * | 2021-12-24 | 2023-06-28 | Isoxa S.r.l. | Isocyclosporin a for topical treatment of ocular diseases |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4649047A (en) * | 1985-03-19 | 1987-03-10 | University Of Georgia Research Foundation, Inc. | Ophthalmic treatment by topical administration of cyclosporin |
| US4839342A (en) * | 1987-09-03 | 1989-06-13 | University Of Georgia Research Foundation, Inc. | Method of increasing tear production by topical administration of cyclosporin |
-
1989
- 1989-10-24 CH CH3835/89A patent/CH679210A5/de not_active IP Right Cessation
- 1989-10-24 BE BE8901138A patent/BE1003578A4/fr not_active IP Right Cessation
- 1989-10-24 FR FR8914023A patent/FR2638089A1/fr active Pending
- 1989-10-25 DE DE3935517A patent/DE3935517A1/de not_active Withdrawn
- 1989-10-25 AU AU43715/89A patent/AU626928B2/en not_active Ceased
- 1989-10-25 GB GB8924040A patent/GB2224205B/en not_active Expired - Lifetime
- 1989-10-25 IL IL9212089A patent/IL92120A/en not_active IP Right Cessation
- 1989-10-25 NZ NZ231131A patent/NZ231131A/en unknown
- 1989-10-25 CA CA002001502A patent/CA2001502A1/en not_active Abandoned
- 1989-10-25 GR GR890100690A patent/GR1000611B/el unknown
- 1989-10-25 HU HU895444A patent/HU203046B/hu not_active IP Right Cessation
- 1989-10-25 DK DK531289A patent/DK531289A/da not_active Application Discontinuation
- 1989-10-25 FI FI895064A patent/FI895064A0/fi not_active Application Discontinuation
- 1989-10-25 JP JP1276174A patent/JPH02164830A/ja active Pending
- 1989-10-25 KR KR1019890015328A patent/KR900005973A/ko not_active Application Discontinuation
- 1989-10-26 PT PT92120A patent/PT92120B/pt not_active IP Right Cessation
- 1989-10-26 LU LU87613A patent/LU87613A1/fr unknown
- 1989-10-26 ES ES8903619A patent/ES2020032A6/es not_active Expired - Lifetime
- 1989-10-26 IT IT04848589A patent/IT1237824B/it active IP Right Grant
- 1989-10-26 NO NO89894266A patent/NO894266L/no unknown
- 1989-10-26 ZA ZA898140A patent/ZA898140B/xx unknown
- 1989-10-26 SE SE8903583A patent/SE8903583L/ not_active Application Discontinuation
- 1989-10-26 NL NL8902657A patent/NL8902657A/nl not_active Application Discontinuation
- 1989-10-26 MY MYPI89001487A patent/MY106271A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL8902657A (nl) | 1990-05-16 |
| BE1003578A4 (fr) | 1992-04-28 |
| DK531289D0 (da) | 1989-10-25 |
| PT92120B (pt) | 1995-06-30 |
| DK531289A (da) | 1990-04-27 |
| ZA898140B (en) | 1991-06-26 |
| NO894266L (no) | 1990-04-27 |
| NO894266D0 (no) | 1989-10-26 |
| LU87613A1 (fr) | 1991-05-07 |
| CA2001502A1 (en) | 1990-04-26 |
| FI895064A0 (fi) | 1989-10-25 |
| DE3935517A1 (de) | 1990-05-03 |
| HU895444D0 (en) | 1990-01-28 |
| ES2020032A6 (es) | 1991-07-16 |
| JPH02164830A (ja) | 1990-06-25 |
| GB8924040D0 (en) | 1989-12-13 |
| MY106271A (en) | 1995-04-29 |
| IT8948485A0 (it) | 1989-10-26 |
| FR2638089A1 (fr) | 1990-04-27 |
| GB2224205B (en) | 1992-04-15 |
| GR1000611B (el) | 1992-08-31 |
| IL92120A0 (en) | 1990-07-12 |
| IL92120A (en) | 1994-02-27 |
| HUT52394A (en) | 1990-07-28 |
| HU203046B (en) | 1991-05-28 |
| SE8903583D0 (sv) | 1989-10-26 |
| GB2224205A (en) | 1990-05-02 |
| PT92120A (pt) | 1990-04-30 |
| SE8903583L (sv) | 1990-04-27 |
| NZ231131A (en) | 1992-06-25 |
| AU4371589A (en) | 1990-05-03 |
| KR900005973A (ko) | 1990-05-07 |
| GR890100690A (en) | 1990-11-29 |
| AU626928B2 (en) | 1992-08-13 |
| IT1237824B (it) | 1993-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH679210A5 (el) | ||
| EP0616801B1 (de) | Verfahren zur Herstellung einer Liposomendispersion im Hochdruckbereich | |
| DE3915617B4 (de) | Verwendung einer ein Cyclosporin enthaltenden Zusammensetzung zur topischen Applikation | |
| DE69531389T2 (de) | Cyclosporin enthaltende multiple Emulsionen | |
| DE3930928C2 (de) | Cyclosporin enthaltende pharmazeutische Formulierungen | |
| DE69926843T2 (de) | Aktives vitamin-d3 enthaltende lotionen in form von emulsionen | |
| DE3924207C2 (el) | ||
| DE60210568T2 (de) | Coenzym Q10 zur Behandlung von Erkrankungen der Augen | |
| EP0256285A1 (de) | Pharmazeutische Formulierung und Verfahren zu deren Herstellung | |
| DE69731072T2 (de) | Cyclosporin enthaltende weichkapselpräparate | |
| DE2902863A1 (de) | Waessriges gel zur anwendung im bindehautsack | |
| EP0585896B1 (de) | Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks | |
| DE69921409T2 (de) | Cyclosporin enthaltende Zusammensetzungen | |
| DE3330053C2 (el) | ||
| DE3815581A1 (de) | Ophthalmologische zusammensetzung | |
| DE3643119A1 (de) | Therapeutische zusammensetzung fuer diabetes-komplikationen | |
| DE60005992T2 (de) | Verwendung von ubiquinon q 10 zur vorbeugung und behandlung von postoperativen okularen pathologien | |
| DE60017174T2 (de) | Rivastigmine zur behandlung von augenerkrankungen | |
| DE60027878T2 (de) | Verwendung des nervenwachstumfaktors zur herstellung eines arzneimittels zur behandlung von erkrankungen der innenaugegeweb | |
| DE60304458T2 (de) | Verwendung eines l-ascorbinsäuresalzes zur herstellung einer pharmazeutischen zusammensetzung für die ophthalmische topische anwendung zur verbesserung des l-ascorbinsäurespiegels im auge | |
| DE4315921A1 (de) | Cyclosporin(e) enthaltende pharmazeutische Zubereitung zur intravenösen Applikation sowie Verfahren zu ihrer Herstellung | |
| DE2330338A1 (de) | Okular-hypotensives mittel | |
| Grehn et al. | Thymoxamine: a miotic for intraocular use | |
| Naumann et al. | Embryologie, Anatomie und Untersuchungstechnik | |
| DE1617653B1 (de) | Indomethacinpraeparat zur externen Anwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |